NEWS
Our Latest News
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
ARCHIMED initiates the delisting from Korea Exchange of shares in Jeisys Medical, a leading developer of aesthetic medicine devices, after acquiring Jeisys Medical via change-of-control transactions, including public tenders.
ARCHIMED raises €315m for second fund
September
20,
2017
Healthcare Focused Private Equity Firm ARCHIMED Closes Second Fund, at €315M
September
18,
2017
Healthcare-focused private equity firm ARCHIMED has raised a €315m fund in just four months
September
18,
2017
ARCHIMED récolte 315 M€ pour son 2ème véhicule
September
18,
2017
ARCHIMED atteint le hard cap pour son fonds II
September
18,
2017
368